Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir

Clinical trial NCT03236584 · UNKNOWN

Trial details

NCT number: NCT03236584
Sponsor: Uijeongbu St. Mary Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48

Start date: 2015-09-01
Primary completion: 2018-03-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.